FDA Import Refusal AEK-9296321-2/10002/1 — Novo Nordisk A/S
The FDA refused shipment AEK-9296321-2/10002/1 from Novo Nordisk A/S (Denmark) on January 22, 2026. The refused product falls under Drugs and Biologics — INSULIN DEGLUDEC. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- January 22, 2026
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 58HCY07 INSULIN DEGLUDEC
- Charges
- 75